Whalegun
Home

Abraham Ceesay, CEO: Rapport Therapeutics RAPP Sell · Filed 25/11/18

Trade details

Type
Insider sale
Amount
$77,714.08
Shares · price
3,056 sh · $25.43 a share
Held after
573,746 sh
Stock
Rapport Therapeutics RAPP
Person
Abraham CeesayCEO
Trade date
25/11/17
Filed
25/11/18
Days to filing
1 days

Sold 0.5% of holdings

Share of holding sold
0.5%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/18~25/12/17

Abraham Ceesay's recent trades

  • Abraham Ceesay

    Sell10b5-1 planRapport Therapeutics

    $76.2K

    Filed 09/24

  • Abraham Ceesay

    Sell10b5-1 planRapport Therapeutics

    $8,570

    Filed 09/24

  • Abraham Ceesay

    Sell10b5-1 planRapport Therapeutics

    $1,765

    Filed 09/24

  • Abraham Ceesay

    Planned sale10b5-1 planRapport Therapeutics

    $4M

    Filed 06/29

  • Abraham Ceesay

    Planned salePacira BioSciences

    $210.4K

    Filed 06/12

Abraham Ceesay, CEO — sold $77.7K of Rapport Therapeutics RAPP · 0.5% of holdings · 10b5-1 plan | Whalegun